✦ LIBER ✦

Doxorubicin immunoconjugates containing bivalent, lysosomally-Cleavable dipeptide linkages

✍ Scribed by Gene M Dubowchik; Shilpa Radia; Harold Mastalerz; Michael A Walker; Raymond A Firestone; H Dalton King; Sandra J Hofstead; David Willner; Shirley J Lasch; Pamela A Trail

Book ID: 108477207
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 133 KB
Volume: 12
Category: Article
ISSN: 0960-894X
DOI: 10.1016/s0960-894x(02)00194-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Shell cross-linked and hepatocyte-target

Shell cross-linked and hepatocyte-targeting nanoparticles containing doxorubicin via acid-cleavable linkage

✍ Changhai Lu; Malcolm M.Q. Xing; Wen Zhong 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 731 KB

Hepatocyte-targeting and shell cross-linked nanoparticles with lactose moiety on the surface and doxorubicin (DOX) in the core were prepared from lactose-PEG-DOX conjugate. The process consists of the synthesis of a novel α-hydrazine-ω-propargyl poly(ethylene glycol) (PEG) with a double bond in the

Cathepsin B-Labile Dipeptide Linkers for

Cathepsin B-Labile Dipeptide Linkers for Lysosomal Release of Doxorubicin from Internalizing Immunoconjugates: Model Studies of Enzymatic Drug Release and Antigen-Specific In Vitro Anticancer Activity

✍ Dubowchik, Gene M.; Firestone, Raymond A.; Padilla, Linda; Willner, David; Hofst 📂 Article 📅 2002 🏛 American Chemical Society 🌐 English ⚖ 190 KB